Pill imprint M A33 has been identified as Armodafinil 250 mg.
Armodafinil is used in the treatment of shift work sleep disorder; narcolepsy; obstructive sleep apnea/hypopnea syndrome; chronic fatigue syndrome; adhd (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 250 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Pill image: https://www.drugs.com/imprints/m-a33-24859.html
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 7 Jun 2009 • 1 answer
Posted 6 Jan 2010 • 1 answer
Posted 25 Jan 2014 • 1 answer
Posted 5 Mar 2015 • 1 answer
Posted 13 Sep 2016 • 1 answer